氟喹诺酮类抗菌药

氟喹诺酮类抗菌药后效应及其机制的研究

Studies on the Post - antibiotic Effects of Fluoroquinolones and Mechanism

甲磺酸左氧氟沙星（LevofloxacinMesylate，MSALVFX）是本所研制的一种新的氟喹诺酮类抗菌药，是氧氟沙星左旋体的甲磺酸盐。

Prulifloxacin , a new fluoroquinolone antibacterial agent Levofloxacin Mesylate ( MSALVFX ) is a kind of newer fluoroquinolone antibacterial agent developed by our institute . It is a mesylate of levofloxacin .

普卢利沙星&新一代氟喹诺酮类抗菌药

Prulifloxacin , A New Quinolone Antibacterial Drug

就畜禽专用氟喹诺酮类抗菌药恩诺沙星对鸡人工感染大肠杆菌病及葡萄球菌病的药效进行了研究。

The studies dealed with efficacy evaluation of enrofloxacin against colibacillosis and staphylocosis in chickens .

氟喹诺酮类抗菌药马波沙星的研究进展

Advances in Marbofloxacin of Fluoroquinolone Antibiotic

普利沙星是新口服的氟喹诺酮类抗菌药。

Prulifloxacin , a new prodrug of ulifloxacin , is a broad-spectrum oral fluoroquinolone antibacterial agent .

结论大肠埃希氏菌临床分离株对氟喹诺酮类耐药性严重，有指征地选用氟喹诺酮类等广谱抗菌药，是防治FREC感染的关键。

Conclusion : The high resistant rate of clinical strains of Escherichia coli to fluoroquinolones indicated the appropriate uses of fluoroquinolones and other broad spectrum antibacterial agents is critical for controlling infections caused by FREC .